Skip to main content

Illumina to Move Headquarters Down the Road


This story was originally published Jan. 10.

Illumina plans to move its headquarters to a new site in San Diego, according to a filing with the Securities and Exchange Commission last week.

Under the terms of the lease, signed on Dec. 30, Illumina's headquarters will move from its current location just east of the University of California San Diego campus to a larger facility at 5200 Research Place, less than two miles south.

The new site initially consists of two office buildings and a central plant building, totaling about 350,000 square feet. A third office building with 123,000 square feet has yet to be built. In addition, Illumina has the right to further expand and to lease one or more of three additional office buildings that may be built. It also has a right of first refusal regarding sales of the facility to others.

The proposed start date of the 20-year lease is Nov. 1, and Illumina has four five-year options to extend the lease, as well as a one-time option to terminate the lease after 15 years.

The company will pay approximately $335.1 million in rent during the initial term of the lease, not including any expansion buildings.

According to the company's 2009 annual report, as of Jan. 3, 2010 the company was leasing 272,000 square feet of space in San Diego for R&D, manufacturing, storage, distribution, and administrative purchases.

The company also leases 105,000 square feet in Hayward, Calif.; 49,000 square feet in Little Chesterford, UK; 36,000 square feet in Singapore; 11,500 square feet in the Netherlands; 6,500 square feet in Tokyo; 4,000 square feet in Melbourne, Australia; and 3,000 square feet in China.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.